Quality and quantity of survival in acute myeloid leukaemia.
The quality of life in leukaemia is as important as its quantity. In fifty-one patients the quality and quantity of life were improved by less aggressive treatment than is usual. By not trying to induce complete remission at all costs, the mobidity and early mortality were reduced and at least an equivalence in survival was obtained.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D000493:Allopurinol / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005491:Focal Infection, Dental; D005500:Follow-Up Studies; D006801:Humans; D007902:Length of Stay; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy / Q000401:mortality*; D015122:Mercaptopurine / Q000627:therapeutic use; D008875:Middle Aged; D010684:Philosophy; D011788:Quality of Life; D012075:Remission, Spontaneous
D003561:Cytarabine; D000493:Allopurinol; D015122:Mercaptopurine; D003630:Daunorubicin